Company intelligence / Profile preview

AstriVax Therapeutics

Leuven, Flemish Brabant, Belgiumastrivax.com ↗

Ownership: Private
Employees: ~12
Development stage: Phase 1

Overview

Currently conducting first-in-human clinical trials testing two preventive vaccines (yellow fever and rabies) at clinical trial sites in Belgium. The company is also developing therapeutic products for chronic HBV and high-risk HPV.

Therapeutic areas: Infectious Diseases
Modalities: DNA-based immunotherapiesplasmid-launched live attenuated viruses
Industry: Biotech

Drug pipeline

6 assets

AVX70371

5 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on AstriVax Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AstriVax Therapeutics.

Explore the full profile